by Christina Arshadi | Sep 20, 2024 | Blog
Immunotherapies were back in the spotlight at the European Society for Medical Oncology’s congress this year, but its limitations are prompting a strategic realignment. Back in style Our analysis of last year’s ESMO congress discovered a notable focus on...
by Georgi Ivanov | Sep 9, 2024 | Blog
This year’s European Society of Cardiology (ESC) Congress highlighted a narrative shift in cardiology, with prevention and detection gaining more prominence and overshadowing the traditional focus on treatment and management. A change in perspective...
by Sofia Tzamarelou | Jul 23, 2024 | Blog
Pharma PR and comms need new strategies to reduce the stigma around lung cancer, which gets in the way of screening rates and drug development. Lung cancer has a branding problem More people die from lung cancer than any other cancer, and it kills more women than...
by Georgi Ivanov | Jun 10, 2024 | Blog
ASCO’s focus on less invasive treatment suggests a narrative shift in oncology: that doing less — less surgery, less chemotherapy or less radiation — can help patients live longer and feel better. The context: The 2024 edition of the American Society of Clinical...
by Christina Arshadi | Apr 23, 2024 | Blog
As healthcare communicators have struggled to combat statin misinformation with traditional debunking strategies, our study reveals how “pre-bunking” can be much more effective. The context: While statins – the most popular class of...
